{"entity":{"type":"insider","cik":"0001358116","url":"/insider/0001358116","json_url":"/insider/0001358116.json","name":"Skolnick Phil","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":26,"first":"2006-04-05","last":"2023-01-31","span_basis":"filed_date"},"name_variants":[{"name":"Skolnick Phil","source":"filing","n_filings":26,"first_seen":"2006-04-05","last_seen":"2023-01-31"}],"transactions":[{"id":7929138,"accession":"0001385508-23-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-23-000031","line_url":"/filing/0001385508-23-000031#line-1","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":480.0,"shares_display":"480","price_per_share":20.26,"price_display":"20.26","price_state":"stated","total_value":9724.8,"total_display":"9,724.80","total_whole":"9,725","shares_owned_after":21548.0,"shares_owned_after_display":"21,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-31","scope":"insider"},{"id":8230746,"accession":"0001385508-23-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-23-000020","line_url":"/filing/0001385508-23-000020#line-1","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":369.0,"shares_display":"369","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":7453.8,"total_display":"7,453.80","total_whole":"7,454","shares_owned_after":22028.0,"shares_owned_after_display":"22,028","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-09","scope":"insider"},{"id":8303928,"accession":"0001385508-23-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-23-000007","line_url":"/filing/0001385508-23-000007#line-1","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1421.0,"shares_display":"1,421","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":28704.2,"total_display":"28,704.20","total_whole":"28,704","shares_owned_after":22397.0,"shares_owned_after_display":"22,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-05","scope":"insider"},{"id":6583634,"accession":"0001385508-22-000111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000111","line_url":"/filing/0001385508-22-000111#line-1","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":627.0,"shares_display":"627","price_per_share":11.85,"price_display":"11.85","price_state":"stated","total_value":7429.95,"total_display":"7,429.95","total_whole":"7,430","shares_owned_after":23818.0,"shares_owned_after_display":"23,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-14","filed_date":"2022-07-15","scope":"insider"},{"id":6904262,"accession":"0001385508-22-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000026","line_url":"/filing/0001385508-22-000026#line-1","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1518.0,"shares_display":"1,518","price_per_share":26.19,"price_display":"26.19","price_state":"stated","total_value":39756.42,"total_display":"39,756.42","total_whole":"39,756","shares_owned_after":22445.0,"shares_owned_after_display":"22,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-27","filed_date":"2022-01-27","scope":"insider"},{"id":6665392,"accession":"0001385508-22-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000021","line_url":"/filing/0001385508-22-000021#line-1","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":385.0,"shares_display":"385","price_per_share":30.49,"price_display":"30.49","price_state":"stated","total_value":11738.65,"total_display":"11,738.65","total_whole":"11,739","shares_owned_after":23963.0,"shares_owned_after_display":"23,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-12","scope":"insider"},{"id":2750205,"accession":"0001385508-20-000015","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001385508-20-000015","line_url":"/filing/0001385508-20-000015#line-4","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2842.0,"shares_display":"2,842","price_per_share":13.46,"price_display":"13.46","price_state":"stated","total_value":38253.32,"total_display":"38,253.32","total_whole":"38,253","shares_owned_after":7193.0,"shares_owned_after_display":"7,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-01-09","scope":"insider"},{"id":2750200,"accession":"0001385508-20-000015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-20-000015","line_url":"/filing/0001385508-20-000015","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5943.0,"shares_display":"5,943","price_per_share":13.477112569409389,"price_display":"13.48","price_state":"stated","total_value":80094.48,"total_display":"80,094.48","total_whole":"80,094","shares_owned_after":4150.0,"shares_owned_after_display":"4,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-09","scope":"insider","n_lines":2},{"id":2988255,"accession":"0001385508-20-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-20-000002","line_url":"/filing/0001385508-20-000002#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":515.0,"shares_display":"515","price_per_share":13.8,"price_display":"13.80","price_state":"stated","total_value":7107.0,"total_display":"7,107.00","total_whole":"7,107","shares_owned_after":8785.0,"shares_owned_after_display":"8,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-06","filed_date":"2020-01-06","scope":"insider"},{"id":2988250,"accession":"0001385508-20-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-20-000002","line_url":"/filing/0001385508-20-000002#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":14.08,"price_display":"14.08","price_state":"stated","total_value":9856.0,"total_display":"9,856.00","total_whole":"9,856","shares_owned_after":9300.0,"shares_owned_after_display":"9,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"},{"id":8713768,"accession":"0001385508-19-000125","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000125","line_url":"/filing/0001385508-19-000125#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":13.34,"price_display":"13.34","price_state":"stated","total_value":10672.0,"total_display":"10,672.00","total_whole":"10,672","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-06","filed_date":"2019-12-06","scope":"insider"},{"id":8713765,"accession":"0001385508-19-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-19-000125","line_url":"/filing/0001385508-19-000125#line-1","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2057.0,"shares_display":"2,057","price_per_share":13.74,"price_display":"13.74","price_state":"stated","total_value":28263.18,"total_display":"28,263.18","total_whole":"28,263","shares_owned_after":800.0,"shares_owned_after_display":"800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-05","filed_date":"2019-12-06","scope":"insider"},{"id":8401364,"accession":"0001385508-19-000123","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000123","line_url":"/filing/0001385508-19-000123#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4578.0,"shares_display":"4,578","price_per_share":13.93,"price_display":"13.93","price_state":"stated","total_value":63771.54,"total_display":"63,771.54","total_whole":"63,772","shares_owned_after":2857.0,"shares_owned_after_display":"2,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-04","scope":"insider"},{"id":8401360,"accession":"0001385508-19-000123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000123","line_url":"/filing/0001385508-19-000123#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2565.0,"shares_display":"2,565","price_per_share":14.17,"price_display":"14.17","price_state":"stated","total_value":36346.05,"total_display":"36,346.05","total_whole":"36,346","shares_owned_after":7435.0,"shares_owned_after_display":"7,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-04","scope":"insider"},{"id":8713762,"accession":"0001385508-19-000100","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001385508-19-000100","line_url":"/filing/0001385508-19-000100#line-4","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":14.89,"price_display":"14.89","price_state":"stated","total_value":37225.0,"total_display":"37,225.00","total_whole":"37,225","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-05","filed_date":"2019-11-05","scope":"insider"},{"id":8713759,"accession":"0001385508-19-000100","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000100","line_url":"/filing/0001385508-19-000100#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":299.0,"shares_display":"299","price_per_share":15.28,"price_display":"15.28","price_state":"stated","total_value":4568.72,"total_display":"4,568.72","total_whole":"4,569","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-04","filed_date":"2019-11-05","scope":"insider"},{"id":8713754,"accession":"0001385508-19-000100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000100","line_url":"/filing/0001385508-19-000100#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7201.0,"shares_display":"7,201","price_per_share":15.1,"price_display":"15.10","price_state":"stated","total_value":108735.1,"total_display":"108,735.10","total_whole":"108,735","shares_owned_after":2799.0,"shares_owned_after_display":"2,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-01","filed_date":"2019-11-05","scope":"insider"},{"id":7794938,"accession":"0001385508-19-000098","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001385508-19-000098","line_url":"/filing/0001385508-19-000098#line-4","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1609.0,"shares_display":"1,609","price_per_share":14.27,"price_display":"14.27","price_state":"stated","total_value":22960.43,"total_display":"22,960.43","total_whole":"22,960","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-03","filed_date":"2019-10-03","scope":"insider"},{"id":7794936,"accession":"0001385508-19-000098","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000098","line_url":"/filing/0001385508-19-000098#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1102.0,"shares_display":"1,102","price_per_share":14.57,"price_display":"14.57","price_state":"stated","total_value":16056.14,"total_display":"16,056.14","total_whole":"16,056","shares_owned_after":1609.0,"shares_owned_after_display":"1,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-02","filed_date":"2019-10-03","scope":"insider"},{"id":7794935,"accession":"0001385508-19-000098","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000098","line_url":"/filing/0001385508-19-000098#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7289.0,"shares_display":"7,289","price_per_share":14.79,"price_display":"14.79","price_state":"stated","total_value":107804.31,"total_display":"107,804.31","total_whole":"107,804","shares_owned_after":2711.0,"shares_owned_after_display":"2,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-01","filed_date":"2019-10-03","scope":"insider"},{"id":8113131,"accession":"0001385508-19-000090","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000090","line_url":"/filing/0001385508-19-000090#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2494.0,"shares_display":"2,494","price_per_share":14.37,"price_display":"14.37","price_state":"stated","total_value":35838.78,"total_display":"35,838.78","total_whole":"35,839","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-04","filed_date":"2019-09-04","scope":"insider"},{"id":8113126,"accession":"0001385508-19-000090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000090","line_url":"/filing/0001385508-19-000090#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7506.0,"shares_display":"7,506","price_per_share":14.08,"price_display":"14.08","price_state":"stated","total_value":105684.48,"total_display":"105,684.48","total_whole":"105,684","shares_owned_after":2494.0,"shares_owned_after_display":"2,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-04","scope":"insider"},{"id":8423530,"accession":"0001385508-19-000077","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000077","line_url":"/filing/0001385508-19-000077#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1558.0,"shares_display":"1,558","price_per_share":11.3,"price_display":"11.30","price_state":"stated","total_value":17605.4,"total_display":"17,605.40","total_whole":"17,605","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-02","filed_date":"2019-08-02","scope":"insider"},{"id":8423529,"accession":"0001385508-19-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000077","line_url":"/filing/0001385508-19-000077#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8442.0,"shares_display":"8,442","price_per_share":11.66,"price_display":"11.66","price_state":"stated","total_value":98433.72,"total_display":"98,433.72","total_whole":"98,434","shares_owned_after":1558.0,"shares_owned_after_display":"1,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-01","filed_date":"2019-08-02","scope":"insider"},{"id":8624890,"accession":"0001385508-19-000068","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000068","line_url":"/filing/0001385508-19-000068#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2195.0,"shares_display":"2,195","price_per_share":13.16,"price_display":"13.16","price_state":"stated","total_value":28886.2,"total_display":"28,886.20","total_whole":"28,886","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-02","filed_date":"2019-07-02","scope":"insider"},{"id":8624885,"accession":"0001385508-19-000068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000068","line_url":"/filing/0001385508-19-000068#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7805.0,"shares_display":"7,805","price_per_share":13.2,"price_display":"13.20","price_state":"stated","total_value":103026.0,"total_display":"103,026.00","total_whole":"103,026","shares_owned_after":2195.0,"shares_owned_after_display":"2,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-02","scope":"insider"},{"id":7984302,"accession":"0001385508-19-000054","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000054","line_url":"/filing/0001385508-19-000054#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1586.0,"shares_display":"1,586","price_per_share":11.63,"price_display":"11.63","price_state":"stated","total_value":18445.18,"total_display":"18,445.18","total_whole":"18,445","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-04","scope":"insider"},{"id":7984298,"accession":"0001385508-19-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000054","line_url":"/filing/0001385508-19-000054#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8414.0,"shares_display":"8,414","price_per_share":11.72,"price_display":"11.72","price_state":"stated","total_value":98612.08,"total_display":"98,612.08","total_whole":"98,612","shares_owned_after":1586.0,"shares_owned_after_display":"1,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-04","scope":"insider"},{"id":8683058,"accession":"0001385508-19-000047","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000047","line_url":"/filing/0001385508-19-000047#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1441.0,"shares_display":"1,441","price_per_share":11.24,"price_display":"11.24","price_state":"stated","total_value":16196.84,"total_display":"16,196.84","total_whole":"16,197","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-02","filed_date":"2019-05-03","scope":"insider"},{"id":8683054,"accession":"0001385508-19-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000047","line_url":"/filing/0001385508-19-000047#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8559.0,"shares_display":"8,559","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":97658.19,"total_display":"97,658.19","total_whole":"97,658","shares_owned_after":1441.0,"shares_owned_after_display":"1,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-01","filed_date":"2019-05-03","scope":"insider"},{"id":8498669,"accession":"0001385508-19-000035","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000035","line_url":"/filing/0001385508-19-000035#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2007.0,"shares_display":"2,007","price_per_share":12.47,"price_display":"12.47","price_state":"stated","total_value":25027.29,"total_display":"25,027.29","total_whole":"25,027","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-02","filed_date":"2019-04-03","scope":"insider"},{"id":8498665,"accession":"0001385508-19-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000035","line_url":"/filing/0001385508-19-000035#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7993.0,"shares_display":"7,993","price_per_share":12.71,"price_display":"12.71","price_state":"stated","total_value":101591.03,"total_display":"101,591.03","total_whole":"101,591","shares_owned_after":2007.0,"shares_owned_after_display":"2,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-03","scope":"insider"},{"id":7813579,"accession":"0001385508-19-000018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000018","line_url":"/filing/0001385508-19-000018","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.953505,"price_display":"14.95","price_state":"stated","total_value":149535.05,"total_display":"149,535.05","total_whole":"149,535","shares_owned_after":2701.0,"shares_owned_after_display":"2,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-04","scope":"insider","n_lines":2},{"id":8604416,"accession":"0001385508-19-000014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000014","line_url":"/filing/0001385508-19-000014#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2559.0,"shares_display":"2,559","price_per_share":15.31,"price_display":"15.31","price_state":"stated","total_value":39178.29,"total_display":"39,178.29","total_whole":"39,178","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-04","filed_date":"2019-02-04","scope":"insider"},{"id":8604413,"accession":"0001385508-19-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000014","line_url":"/filing/0001385508-19-000014#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7441.0,"shares_display":"7,441","price_per_share":15.32,"price_display":"15.32","price_state":"stated","total_value":113996.12,"total_display":"113,996.12","total_whole":"113,996","shares_owned_after":2559.0,"shares_owned_after_display":"2,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-01","filed_date":"2019-02-04","scope":"insider"},{"id":8604409,"accession":"0001385508-19-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000004","line_url":"/filing/0001385508-19-000004#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2232.0,"shares_display":"2,232","price_per_share":13.48,"price_display":"13.48","price_state":"stated","total_value":30087.36,"total_display":"30,087.36","total_whole":"30,087","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-04","filed_date":"2019-01-04","scope":"insider"},{"id":8604406,"accession":"0001385508-19-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000004","line_url":"/filing/0001385508-19-000004#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7768.0,"shares_display":"7,768","price_per_share":13.84,"price_display":"13.84","price_state":"stated","total_value":107509.12,"total_display":"107,509.12","total_whole":"107,509","shares_owned_after":2232.0,"shares_owned_after_display":"2,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-04","scope":"insider"},{"id":6376784,"accession":"0001385508-18-000117","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-18-000117","line_url":"/filing/0001385508-18-000117#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3015.0,"shares_display":"3,015","price_per_share":16.15,"price_display":"16.15","price_state":"stated","total_value":48692.25,"total_display":"48,692.25","total_whole":"48,692","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-06","scope":"insider"},{"id":6376779,"accession":"0001385508-18-000117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-18-000117","line_url":"/filing/0001385508-18-000117#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1306.0,"shares_display":"1,306","price_per_share":15.85,"price_display":"15.85","price_state":"stated","total_value":20700.1,"total_display":"20,700.10","total_whole":"20,700","shares_owned_after":3015.0,"shares_owned_after_display":"3,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6639142,"accession":"0001385508-18-000111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-18-000111","line_url":"/filing/0001385508-18-000111#line-1","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3217.0,"shares_display":"3,217","price_per_share":16.81,"price_display":"16.81","price_state":"stated","total_value":54077.77,"total_display":"54,077.77","total_whole":"54,078","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-06","filed_date":"2018-11-08","scope":"insider"},{"id":6666092,"accession":"0001385508-18-000104","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-18-000104","line_url":"/filing/0001385508-18-000104#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":17.33,"price_display":"17.33","price_state":"stated","total_value":5199.0,"total_display":"5,199.00","total_whole":"5,199","shares_owned_after":3217.0,"shares_owned_after_display":"3,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-05","filed_date":"2018-11-05","scope":"insider"},{"id":6666089,"accession":"0001385508-18-000104","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-18-000104","line_url":"/filing/0001385508-18-000104#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1521.0,"shares_display":"1,521","price_per_share":18.14,"price_display":"18.14","price_state":"stated","total_value":27590.94,"total_display":"27,590.94","total_whole":"27,591","shares_owned_after":3517.0,"shares_owned_after_display":"3,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-05","scope":"insider"},{"id":6790528,"accession":"0001385508-18-000088","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001385508-18-000088","line_url":"/filing/0001385508-18-000088#line-4","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1845.0,"shares_display":"1,845","price_per_share":18.43,"price_display":"18.43","price_state":"stated","total_value":34003.35,"total_display":"34,003.35","total_whole":"34,003","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-04","filed_date":"2018-10-04","scope":"insider"},{"id":6790523,"accession":"0001385508-18-000088","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-18-000088","line_url":"/filing/0001385508-18-000088#line-3","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":19.225,"price_display":"19.22","price_state":"stated","total_value":28837.5,"total_display":"28,837.50","total_whole":"28,838","shares_owned_after":1845.0,"shares_owned_after_display":"1,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-03","filed_date":"2018-10-04","scope":"insider"},{"id":6790516,"accession":"0001385508-18-000088","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-18-000088","line_url":"/filing/0001385508-18-000088#line-2","is_derivative":false,"issuer_cik":"0001358116","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001358116","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1433.0,"shares_display":"1,433","price_per_share":17.24,"price_display":"17.24","price_state":"stated","total_value":24704.92,"total_display":"24,704.92","total_whole":"24,705","shares_owned_after":3345.0,"shares_owned_after_display":"3,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-02","filed_date":"2018-10-04","scope":"insider"},{"id":4885137,"accession":"0001005477-06-002064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005477-06-002064","line_url":"/filing/0001005477-06-002064#line-2","is_derivative":false,"issuer_cik":"0001066833","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0001066833","owner_cik":"0001358116","owner_name":"Skolnick Phil","owner_display_name":"Skolnick Phil","owner_url":"/insider/0001358116","role":"Officer (Sr. V.P. Research, CSO)","role_mark":"O","role_mark_label":"Officer (Sr. V.P. Research, CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. V.P. Research, CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.052,"price_display":"16.05","price_state":"stated","total_value":80260.0,"total_display":"80,260.00","total_whole":"80,260","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-04-03","filed_date":"2006-04-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":48,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001385508","name":"OPIANT PHARMACEUTICALS, INC.","url":"/issuer/0001385508","role":"Officer (Chief Scientific Officer)","n_filings":25,"first_seen":"2018-10-04","last_seen":"2023-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001066833","name":"DOV PHARMACEUTICAL INC","url":"/issuer/0001066833","role":"Officer (Sr. V.P. Research, CSO)","n_filings":1,"first_seen":"2006-04-05","last_seen":"2006-04-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001358116","retrieved_at":"2026-08-25T14:55:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}